Cargando…
Early HIV-1 Envelope-specific Cytotoxic T Lymphocyte Responses in Vertically Infected Infants
High frequencies of cytotoxic T lymphocyte precursors (CTLp) recognizing HIV-1 laboratory strain gene products have been detected in adults within weeks of primary infection. In contrast, HIV-1–specific CTLp are uncommonly detected in infants younger than 6 mo. To address the hypothesis that the use...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2196268/ https://www.ncbi.nlm.nih.gov/pubmed/9104802 |
_version_ | 1782148026861617152 |
---|---|
author | Pikora, Cheryl A. Sullivan, John L. Panicali, Dennis Luzuriaga, Katherine |
author_facet | Pikora, Cheryl A. Sullivan, John L. Panicali, Dennis Luzuriaga, Katherine |
author_sort | Pikora, Cheryl A. |
collection | PubMed |
description | High frequencies of cytotoxic T lymphocyte precursors (CTLp) recognizing HIV-1 laboratory strain gene products have been detected in adults within weeks of primary infection. In contrast, HIV-1–specific CTLp are uncommonly detected in infants younger than 6 mo. To address the hypothesis that the use of target cells expressing laboratory strain env gene products might limit the detection of HIV-1 env-specific CTLp in early infancy, recombinant vaccinia vectors (vv) expressing HIV-1 env genes from early isolates of four vertically infected infants were generated. The frequencies of CTLp recognizing target cells infected with vv-expressing env gene products from early isolates and HIV-1 IIIB were serially measured using limiting dilution followed by in vitro stimulation with mAb to CD3. In one infant, the detection of early isolate env-specific CTLp preceded the detection of IIIB-specific CTLp. CTLp recognizing HIV-1 IIIB and infant isolate env were detected by 6 mo of age in two infants. In a fourth infant, HIV-1 IIIB env and early isolate env-specific CTLp were simultaneously detected at 12 mo of age. These results provide evidence that young infants can generate HIV-1–specific CTL responses and provide support for the concept of neonatal vaccination to prevent HIV-1 transmission. However, the early predominance of type-specific CTL detected in some young infants suggests that the use of vaccines based on laboratory strains of HIV-1 may not protect against vertical infection. |
format | Text |
id | pubmed-2196268 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1997 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-21962682008-04-16 Early HIV-1 Envelope-specific Cytotoxic T Lymphocyte Responses in Vertically Infected Infants Pikora, Cheryl A. Sullivan, John L. Panicali, Dennis Luzuriaga, Katherine J Exp Med Article High frequencies of cytotoxic T lymphocyte precursors (CTLp) recognizing HIV-1 laboratory strain gene products have been detected in adults within weeks of primary infection. In contrast, HIV-1–specific CTLp are uncommonly detected in infants younger than 6 mo. To address the hypothesis that the use of target cells expressing laboratory strain env gene products might limit the detection of HIV-1 env-specific CTLp in early infancy, recombinant vaccinia vectors (vv) expressing HIV-1 env genes from early isolates of four vertically infected infants were generated. The frequencies of CTLp recognizing target cells infected with vv-expressing env gene products from early isolates and HIV-1 IIIB were serially measured using limiting dilution followed by in vitro stimulation with mAb to CD3. In one infant, the detection of early isolate env-specific CTLp preceded the detection of IIIB-specific CTLp. CTLp recognizing HIV-1 IIIB and infant isolate env were detected by 6 mo of age in two infants. In a fourth infant, HIV-1 IIIB env and early isolate env-specific CTLp were simultaneously detected at 12 mo of age. These results provide evidence that young infants can generate HIV-1–specific CTL responses and provide support for the concept of neonatal vaccination to prevent HIV-1 transmission. However, the early predominance of type-specific CTL detected in some young infants suggests that the use of vaccines based on laboratory strains of HIV-1 may not protect against vertical infection. The Rockefeller University Press 1997-04-07 /pmc/articles/PMC2196268/ /pubmed/9104802 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Article Pikora, Cheryl A. Sullivan, John L. Panicali, Dennis Luzuriaga, Katherine Early HIV-1 Envelope-specific Cytotoxic T Lymphocyte Responses in Vertically Infected Infants |
title | Early HIV-1 Envelope-specific Cytotoxic T Lymphocyte Responses in Vertically Infected Infants |
title_full | Early HIV-1 Envelope-specific Cytotoxic T Lymphocyte Responses in Vertically Infected Infants |
title_fullStr | Early HIV-1 Envelope-specific Cytotoxic T Lymphocyte Responses in Vertically Infected Infants |
title_full_unstemmed | Early HIV-1 Envelope-specific Cytotoxic T Lymphocyte Responses in Vertically Infected Infants |
title_short | Early HIV-1 Envelope-specific Cytotoxic T Lymphocyte Responses in Vertically Infected Infants |
title_sort | early hiv-1 envelope-specific cytotoxic t lymphocyte responses in vertically infected infants |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2196268/ https://www.ncbi.nlm.nih.gov/pubmed/9104802 |
work_keys_str_mv | AT pikoracheryla earlyhiv1envelopespecificcytotoxictlymphocyteresponsesinverticallyinfectedinfants AT sullivanjohnl earlyhiv1envelopespecificcytotoxictlymphocyteresponsesinverticallyinfectedinfants AT panicalidennis earlyhiv1envelopespecificcytotoxictlymphocyteresponsesinverticallyinfectedinfants AT luzuriagakatherine earlyhiv1envelopespecificcytotoxictlymphocyteresponsesinverticallyinfectedinfants |